274 related articles for article (PubMed ID: 7858849)
1. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo.
Humphries RG; Tomlinson W; Clegg JA; Ingall AH; Kindon ND; Leff P
Br J Pharmacol; 1995 Jul; 115(6):1110-6. PubMed ID: 7582510
[TBL] [Abstract][Full Text] [Related]
3. P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.
Piper AS; Hollingsworth M
Br J Pharmacol; 1996 Apr; 117(8):1721-9. PubMed ID: 8732282
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
Bailey SJ; Hourani SM
Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645
[TBL] [Abstract][Full Text] [Related]
5. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
6. Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.
Hoyle CH; Edwards GA
Br J Pharmacol; 1992 Oct; 107(2):367-74. PubMed ID: 1422586
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands.
Crack BE; Beukers MW; McKechnie KC; Ijzerman AP; Leff P
Br J Pharmacol; 1994 Dec; 113(4):1432-8. PubMed ID: 7889301
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase.
Crack BE; Pollard CE; Beukers MW; Roberts SM; Hunt SF; Ingall AH; McKechnie KC; IJzerman AP; Leff P
Br J Pharmacol; 1995 Jan; 114(2):475-81. PubMed ID: 7533620
[TBL] [Abstract][Full Text] [Related]
9. Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder.
Aronsson P; Andersson M; Ericsson T; Giglio D
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):603-13. PubMed ID: 20406212
[TBL] [Abstract][Full Text] [Related]
10. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
von Kügelgen I; Späth L; Starke K
Br J Pharmacol; 1994 Nov; 113(3):815-22. PubMed ID: 7858872
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H
Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560
[TBL] [Abstract][Full Text] [Related]
12. P2-purinoceptor antagonists: I. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates.
Bültmann R; Pause B; Wittenburg H; Kurz G; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):481-90. PubMed ID: 8897452
[TBL] [Abstract][Full Text] [Related]
13. The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.
Hoyle CH; Ziganshin AU; Pintor J; Burnstock G
Br J Pharmacol; 1996 Jul; 118(5):1294-300. PubMed ID: 8818356
[TBL] [Abstract][Full Text] [Related]
14. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
von Kügelgen I; Stoffel D; Starke K
Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
[TBL] [Abstract][Full Text] [Related]
15. Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.
Najbar AT; Li CG; Rand MJ
Br J Pharmacol; 1996 Jun; 118(3):537-42. PubMed ID: 8762075
[TBL] [Abstract][Full Text] [Related]
16. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
Trezise DJ; Kennedy I; Humphrey PP
Br J Pharmacol; 1994 May; 112(1):282-8. PubMed ID: 8032652
[TBL] [Abstract][Full Text] [Related]
17. Design and pharmacology of selective P2-purinoceptor antagonists.
Lambrecht G
J Auton Pharmacol; 1996 Dec; 16(6):341-4. PubMed ID: 9131412
[TBL] [Abstract][Full Text] [Related]
18. The purinoceptors of the guinea-pig isolated taenia caeci.
Piper AS; Hollingsworth M
Eur J Pharmacol; 1995 Jul; 280(2):125-34. PubMed ID: 7589176
[TBL] [Abstract][Full Text] [Related]
19. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
Palea S; Corsi M; Pietra C; Artibani W; Calpista A; Gaviraghi G; Trist DG
J Pharmacol Exp Ther; 1994 Apr; 269(1):193-7. PubMed ID: 8169824
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
Ziganshin AU; Hoyle CH; Lambrecht G; Mutschler E; Bümert HG; Burnstock G
Br J Pharmacol; 1994 Mar; 111(3):923-9. PubMed ID: 8019770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
